Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials

BACKGROUND: Acinetobacter infections, especially multidrug-resistant (MDR) Acinetobacter infections, are a global health problem. This study aimed to describe clinical outcomes in patients with confirmed Acinetobacter spp. isolates who were treated with tigecycline in randomized clinical trials. MAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Tucker, Hal, Wible, Michele, Gandhi, Ashesh, Quintana, Alvaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679678/
https://www.ncbi.nlm.nih.gov/pubmed/29138583
http://dx.doi.org/10.2147/IDR.S143306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679678/
https://www.ncbi.nlm.nih.gov/pubmed/29138583
http://dx.doi.org/10.2147/IDR.S143306

Ejemplares similares